BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5733863)

  • 1. [VI-antibody formation in typhoid patients treated with VI-antigen, pentoxyl and levomycetin].
    Kuliev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):55-9. PubMed ID: 5733863
    [No Abstract]   [Full Text] [Related]  

  • 2. [The content of Vi-antibodies and 7S Vi-antibodies in the serum of typhoid patients treated with Vi-antigen and levomycetin].
    Sukhoroslova LI; Andreeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):83-7. PubMed ID: 5733721
    [No Abstract]   [Full Text] [Related]  

  • 3. [The relationship between the indices of the indirect hemagglutination test using antigen from antoclaved cultures of typhoid bacteria, and the method of treating typhoid patients].
    Kuliev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):47-51. PubMed ID: 5735288
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
    Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of the hemagglutination test for detecting Vi-antibodies in the sera of patients with typhoid fever and chronic carrier state during treatment with levomycetin].
    Anan'ina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):146. PubMed ID: 6003869
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic shifts in typhoid patients following immuno-antibiotic therapy with levomycetin and VI-antigen according to the results of the passive VI-hemagglutination test].
    Shneĭder VP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):26-32. PubMed ID: 6004905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term observations for Vi-antibody formation in patients following typhoid fever, treated with Vi-antigen in combination with levomycetin].
    Shneĭder VP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):146. PubMed ID: 5615960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in serum bactericidal properties in patients with typhoid fever and chronic carrier state treated with levomycetin].
    Anan'ina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):98-101. PubMed ID: 4976155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers].
    Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
    Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
    Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Typhoid fever. Prevention and treatment].
    González Lahoz JM; Ribera Casado JM
    Rev Sanid Hig Publica (Madr); 1986; 60(5-6):451-62. PubMed ID: 3492750
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative assessment of the treatment of abdominal typhus with levomycetin, and combination of levomycetin with Vi-antigen and pentoxyl].
    Kuliev MM
    Pediatriia; 1969 Feb; 48(2):79-80. PubMed ID: 5822202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of development of the bacterial carrier state through vaccine-antibiotic therapy of patients with typhoid and paratyphoid. 1. Pecularities of the course of thyphoid and paratyphoid in the complex therapy of patients with levomycetin and dry alcoholic typhoid-paratyphoid B divaccine].
    Bilibin AF; Musabaev IK; Medvedev AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):107-12. PubMed ID: 4965909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrent typhoid in patients treated with levomycetin].
    Shneĭder VP
    Klin Med (Mosk); 1966 Dec; 44(12):124-8. PubMed ID: 6004337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of antibiotics on the formation of typhoid-paratyphoid bacteria carrier states].
    Ukhov AIa
    Antibiotiki; 1969 Aug; 14(8):763-7. PubMed ID: 4985087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of typhoid fever patients with high doses of Vi-antigen in association with levomycetin].
    Bunin KV; Sukhoroslova LI
    Sov Med; 1968 Sep; 31(9):17-22. PubMed ID: 5747026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody formation following aerosol and subcutaneous administration of typhoid antigen].
    Egorva NB; Moskatel'nikova TT
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):144-5. PubMed ID: 4450871
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy of using complex immuno-antibiotic therapy in patients with typhus abdominalis].
    Kuliev MM
    Sov Med; 1969 Jun; 32(6):80-4. PubMed ID: 5802797
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pentoxyl and levomycetin and of their combination on agglutinin formation in experimental immunization with the typhoid vaccine.
    KALININ BIu
    Antibiotiki; 1962 Sep; 7():790-4. PubMed ID: 14042069
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of development of carriers in typhoid and paratyphoid fever.
    Kilesso VA; Bilibin AF; Tendetnik YY; Kornilova II; Antonova IV; Musabayev IK; Nevsky MV; Kusminova ML; Vasilyeva AV
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):95-103. PubMed ID: 4196796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.